Pomerantz Issues Class-Action Reminder to Duolingo Shareholders
Pomerantz LLP issued a reminder to Duolingo shareholders regarding a class action.
Related stories
Hangzhou SDIC Microelectronics and Controlling Shareholder Probed by Regulator
The company says it and its controlling shareholder are under investigation over suspected information disclosure violations.
L impact | REGULATION | Nov 02, 2026, 01:41 PM UTC
FDA Places Bright Minds Biosciences Seizure Drug Application on Partial Hold
Bright Minds Biosciences said the FDA placed its drug application and planned trial for a seizure treatment on partial clinical hold following a review. The stock fell 36% to $35 i
M impact | REGULATION | Nov 02, 2026, 01:19 PM UTC
NRx Pharmaceuticals Receives FDA Approval for Preservative-Free Ketamine
NRx Pharmaceuticals said the FDA approved its preservative-free ketamine application ahead of the agency’s November 10 goal date.
M impact | REGULATION | Nov 02, 2026, 01:13 PM UTC
UniQure Says FDA Accepts Application for Huntington’s Gene Therapy
UniQure said the FDA accepted an application for its potential Huntington’s disease gene therapy.
L impact | REGULATION | Nov 02, 2026, 01:06 PM UTC
Catheter Precision Announces FDA 510(k) Clearance for VIVO System
The clearance enables use of the VIVO system in a broader patient population.
L impact | REGULATION | Nov 02, 2026, 01:05 PM UTC
Lupin Receives U.S. FDA Approval for Amifampridine Tablets
M impact | REGULATION | Nov 02, 2026, 12:34 PM UTC